Innovations in Behavioral Health:
Psychedelic Medicine: Old Compounds, New Beginnings

Wednesday, July 14, 2021 | 12:00 - 1:30pm ET

BOSTON, MA USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- JULY 12, 2021: The need for treatment of mental illness and substance use disorders continues to grow. The unrelenting burden, high costs of care, unmet demand, and gaps in efficacy all create a considerable opportunity for innovation. A new class of pharmaceuticals--psychedelic medicines--is among the emerging therapies and business models attracting attention. In more tightly linking psychotherapy and psychopharmaceutical approaches, these medicines offer the potential for significant impact. However, beyond the demonstration of effectiveness, the adoption of such treatments and the creation of broad access will also require disruption of existing business models, exploring new approaches to drug development, and confronting the historical context regarding psychedelics and society.

Join us Wednesday, July 14th from 12-1:30 ET for a discussion among experts from Yale-New Haven Hospital, Beacon Health Options, Field Trip and MAPS Public Benefit Corporation working in this area as we explore the questions related to bringing this class of therapies to market, including:

  • How will these innovations integrate into the current ecosystem – augmentation versus disruption?
  • What are the considerations regarding health equity?
  • Beyond demonstrating efficacy, what are the key barriers to adoption?
  • What are the implications for clinicians, drug developers, payers, and patients?



Expert Panel


Joy Sun Cooper, MBA
Head of Commercialization and Patient Access, MAPS Public Benefit Corporation

Joseph del Moral
Co-Founder and Chief Executive Officer, Field Trip

John Krystal, MD
Chair and Chief of Psychiatry, Yale-New Haven Hospital

Neil Leibowitz, MD, JD
Chief Medical Officer, Beacon Health Options

Mike Apkon, MD, PhD, MBA
President, Sand Street Advisors, NEHI Board Member (Moderator)

Dan Grossman
Managing Director & Senior Partner, Boston Consulting Group (Closing Remarks)


FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:

For changes or additions, please email your request to: listmgr@HealthCareUpdateNewsService.com.

For removal of your e-mail address, please click the "SafeUnsubscribe" link located in the footer of this message below to automatically remove your address from the list.